Annual Non Current Assets
$237.78 M
-$82.11 M-25.67%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual long term assets is $237.78 million, with the most recent change of -$82.11 million (-25.67%) on December 31, 2023.
- During the last 3 years, IRWD annual non current assets has risen by +$174.39 million (+275.06%).
- IRWD annual non current assets is now -37.70% below its all-time high of $381.70 million, reached on December 31, 2021.
Performance
IRWD Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$210.91 M
-$6.53 M-3.00%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly long term assets is $210.91 million, with the most recent change of -$6.53 million (-3.00%) on September 30, 2024.
- Over the past year, IRWD quarterly non current assets has stayed the same.
- IRWD quarterly non current assets is now -45.49% below its all-time high of $386.95 million, reached on June 30, 2021.
Performance
IRWD Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
IRWD Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -25.7% | 0.0% |
3 y3 years | +275.1% | -44.7% |
5 y5 years | +262.4% | -44.7% |
IRWD Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -37.7% | at low | -44.7% | at low |
5 y | 5-year | -37.7% | +275.1% | -45.5% | +257.4% |
alltime | all time | -37.7% | +1321.0% | -45.5% | +580.3% |
Ironwood Pharmaceuticals Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $210.91 M(-3.0%) |
Jun 2024 | - | $217.44 M(-5.7%) |
Mar 2024 | - | $230.65 M(-3.0%) |
Dec 2023 | $233.29 M(-70.1%) | $237.78 M(-12.1%) |
Sep 2023 | - | $270.45 M(-5.3%) |
Jun 2023 | - | $285.62 M(-1.1%) |
Mar 2023 | - | $288.90 M(-9.7%) |
Dec 2022 | $780.63 M(+4.8%) | $319.89 M(-6.3%) |
Sep 2022 | - | $341.35 M(-4.6%) |
Jun 2022 | - | $357.86 M(-4.1%) |
Mar 2022 | - | $373.28 M(-2.2%) |
Dec 2021 | $745.23 M(+50.3%) | $381.70 M(-0.6%) |
Sep 2021 | - | $384.00 M(-0.8%) |
Jun 2021 | - | $386.95 M(+533.3%) |
Mar 2021 | - | $61.10 M(-3.6%) |
Dec 2020 | $495.84 M(+61.6%) | $63.40 M(+7.4%) |
Sep 2020 | - | $59.01 M(-14.8%) |
Jun 2020 | - | $69.26 M(-1.1%) |
Mar 2020 | - | $70.06 M(-26.9%) |
Dec 2019 | $306.85 M(+15.2%) | $95.90 M(+25.0%) |
Sep 2019 | - | $76.70 M(-19.0%) |
Jun 2019 | - | $94.74 M(-41.4%) |
Mar 2019 | - | $161.71 M(+146.4%) |
Dec 2018 | $266.44 M(-14.5%) | $65.61 M(-61.0%) |
Sep 2018 | - | $168.10 M(-50.4%) |
Jun 2018 | - | $338.68 M(+14.7%) |
Mar 2018 | - | $295.37 M(+0.4%) |
Dec 2017 | $311.60 M(-18.0%) | $294.08 M(-5.5%) |
Sep 2017 | - | $311.03 M(-14.5%) |
Jun 2017 | - | $363.59 M(+5.9%) |
Mar 2017 | - | $343.47 M(+4.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2016 | $380.18 M(-24.0%) | $329.64 M(-5.6%) |
Sep 2016 | - | $349.17 M(+11.2%) |
Jun 2016 | - | $314.07 M(+191.8%) |
Mar 2016 | - | $107.62 M(-9.5%) |
Dec 2015 | $500.20 M(+73.5%) | $118.92 M(+10.5%) |
Sep 2015 | - | $107.65 M(-15.2%) |
Jun 2015 | - | $126.98 M(+204.9%) |
Mar 2015 | - | $41.65 M(+1.6%) |
Dec 2014 | $288.31 M(+25.8%) | $41.02 M(-2.5%) |
Sep 2014 | - | $42.09 M(-7.1%) |
Jun 2014 | - | $45.30 M(-4.8%) |
Mar 2014 | - | $47.57 M(-4.6%) |
Dec 2013 | $229.13 M(+24.2%) | $49.83 M(-0.4%) |
Sep 2013 | - | $50.02 M(+3.7%) |
Jun 2013 | - | $48.25 M(-2.4%) |
Mar 2013 | - | $49.46 M(+8.8%) |
Dec 2012 | $184.44 M(+10.1%) | $45.47 M(+2.9%) |
Sep 2012 | - | $44.17 M(+3.7%) |
Jun 2012 | - | $42.58 M(-0.8%) |
Mar 2012 | - | $42.91 M(+3.6%) |
Dec 2011 | $167.57 M(-35.3%) | $41.41 M(+1.7%) |
Sep 2011 | - | $40.71 M(-1.5%) |
Jun 2011 | - | $41.34 M(-3.8%) |
Mar 2011 | - | $42.97 M(+1.6%) |
Dec 2010 | $259.07 M(+97.1%) | $42.29 M(+5.9%) |
Jun 2010 | - | $39.92 M(+25.8%) |
Mar 2010 | - | $31.73 M(+2.4%) |
Dec 2009 | $131.45 M(+24.3%) | $31.00 M(-2.7%) |
Sep 2009 | - | $31.85 M(-2.4%) |
Dec 2008 | $105.73 M(-11.3%) | $32.64 M |
Dec 2007 | $119.17 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual non current assets year-on-year change?
- What is Ironwood Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly non current assets year-on-year change?
What is Ironwood Pharmaceuticals annual long term assets?
The current annual non current assets of IRWD is $237.78 M
What is the all time high annual non current assets for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual long term assets is $381.70 M
What is Ironwood Pharmaceuticals annual non current assets year-on-year change?
Over the past year, IRWD annual long term assets has changed by -$82.11 M (-25.67%)
What is Ironwood Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of IRWD is $210.91 M
What is the all time high quarterly non current assets for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly long term assets is $386.95 M
What is Ironwood Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, IRWD quarterly long term assets has changed by $0.00 (0.00%)